Adidas’s German headquarters raided in connection with tax investigation

Adidas’s German headquarters raided in connection with tax investigation


The “Arena” office building at the headquarters of the sporting goods manufacturer adidas AG is reflected in an artificial lake.

Daniel Karmann | Picture Alliance | Getty Images

Adidas’s German headquarters were raided on Tuesday in connection with a years-long tax investigation, the company confirmed to CNBC in a statement. 

Authorities are investigating customs and tax regulations for products imported into Germany over a roughly five-year period from October 2019 to August of this year, a spokesperson said. 

Offices at the company’s headquarters in Herzogenaurach, along with other locations, were searched. Adidas said it has provided investigators with relevant documents and information and has previously been in contact with customs authorities about the matter over the last several years.

“The company does not expect any significant financial impact in connection with the investigation,” Adidas said in the statement. 

The company said it “continues to work closely with the customs authorities to also clarify issues arising from different interpretations of German and European law.”

The tax investigation is the latest scandal to hit the sneaker maker after its disastrous breakup with Ye, the rapper formerly known as Kanye West, over antisemitic comments he made.

No additional details about the tax investigation were immediately known. Shares were up slightly in extended trading.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More